RF
EVH icon

Rubicon Founders’s Evolent Health EVH Stock Holding History

Rubicon Founders’s Portfolio EVH Stock Details EVH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$31.5M Hold
5,816,123
– – 16.05% 2
2026
Q1 		$13.3M Hold
5,816,123
– – 9.64% 2
2025
Q4 		$23.3M Hold
5,816,123
– – 14.14% 2
2025
Q3 		$49.2M Hold
5,816,123
– – 24.67% 2
2025
Q2 		$65.5M Buy
5,816,123
+5,162,600
+790% +$47.4M 30.78% 2
2025
Q1 		$6.19M Buy
+653,523
New +$6.6M 3.81% 3

Other funds holding EVH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CCM
Cadian Capital Management New York $1.32B AUM 4.19% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
EC
Engaged Capital Newport Beach, California $327M AUM 22.96% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Rubicon Founders's EVH Position: Q2 2026 in Review

Rubicon Founders held its Evolent Health (EVH) position steady in Q2 2026 at 5,816,123 shares worth $31.5M. The position accounts for 16.05% of the portfolio, ranked #2.

Rubicon Founders first reported a position in EVH in Q1 2025 and has held it in 6 quarters since. The position peaked at $65.5M in Q2 2025. 199 funds tracked by Wall St. Rank hold EVH as of Q2 2026.

  • Rubicon Founders held 5,816,123 shares of Evolent Health worth $31.5M as of Q2 2026.
  • Rubicon Founders left its Evolent Health share count unchanged in Q2 2026.
  • Evolent Health made up 16.05% of Rubicon Founders's portfolio in Q2 2026, its #2 holding.
  • Rubicon Founders first reported a position in Evolent Health in Q1 2025 and has held it in 6 quarters since.
  • Rubicon Founders's Evolent Health position peaked at $65.5M in Q2 2025.
  • 199 funds tracked by Wall St. Rank held Evolent Health as of Q2 2026.

Based on Rubicon Founders's 13F filing for Q2 2026, filed 14 Aug 2026.